ID

24623

Description

Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00508404

Link

https://clinicaltrials.gov/show/NCT00508404

Keywords

Versions (1)
  1. 8/9/17 8/9/17 -
Uploaded on

August 9, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Metastatic Colorectal Cancer NCT00508404

English

Eligibility Metastatic Colorectal Cancer NCT00508404

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with histologically- or cytologically-confirmed metastatic adenocarcinoma of the colon and/or rectum.
Description

COLON ADENOCARCINOMA METASTATIC | Adenocarcinoma of rectum metastatic

Data type

boolean

Alias
UMLS CUI [1]
C0742581
UMLS CUI [2,1]
C0149978
UMLS CUI [2,2]
C1522484
measurable disease according to modified recist guidelines.
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
eastern cooperative oncology group (ecog) performance status of 0, 1 or 2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
paraffin-embedded tissue or unstained tumour slides from primary or metastatic tumour available for central lab analysis.
Description

Primary tumor Paraffin Embedded Tissue Available | Neoplasm Metastasis Paraffin Embedded Tissue Available | Primary tumor Unstained Specimen Available | Neoplasm Metastasis Unstained Specimen Available

Data type

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C1519524
UMLS CUI [1,3]
C0470187
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C1519524
UMLS CUI [2,3]
C0470187
UMLS CUI [3,1]
C0677930
UMLS CUI [3,2]
C1883469
UMLS CUI [3,3]
C0470187
UMLS CUI [4,1]
C0027627
UMLS CUI [4,2]
C1883469
UMLS CUI [4,3]
C0470187
adequate haematologic, renal, hepatic and metabolic function.
Description

Hematologic function | Renal function | Liver function | Metabolic function normal

Data type

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
UMLS CUI [4]
C0438212
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
central nervous system metastases.
Description

CNS metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
prior systemic therapy for the treatment of metastatic colorectal carcinoma with the exception of adjuvant fluoropyrimidine-based chemotherapy given at least six months prior to initiating study treatment.
Description

Systemic therapy Colorectal cancer metastatic | Exception Adjuvant Chemotherapy Fluoropyrimidine

Data type

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0948380
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0085533
UMLS CUI [2,3]
C0596581
prior anti-egfr antibody therapy (e.g.: cetuximab) or treatment with small molecule egfr tyrosine kinase inhibitors (e.g.: erlotinib).
Description

EGFR Antibody Therapeutic procedure | cetuximab | Small Molecule EGFR Tyrosine Kinase Inhibitor Therapy | erlotinib

Data type

boolean

Alias
UMLS CUI [1,1]
C4055105
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0995188
UMLS CUI [3,1]
C1328819
UMLS CUI [3,2]
C3899317
UMLS CUI [4]
C1135135
prior radiotherapy within 14 days prior to screening, and for which all signs of early radiological toxicity have not abated.
Description

Therapeutic radiology procedure | Toxicity Signs Abate Lacking

Data type

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C0311392
UMLS CUI [2,3]
C3853704
UMLS CUI [2,4]
C0332268
significant cardiovascular disease including unstable angina or myocardial infarction within six months before initiating study treatment or a history of ventricular arrhythmia.
Description

Cardiovascular Diseases | Angina, Unstable | Myocardial Infarction | Ventricular arrhythmia

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0085612
history of interstitial pneumonitis or pulmonary fibrosis or evidence of interstitial pneumonitis or pulmonary fibrosis on baseline chest ct scan.
Description

Interstitial Pneumonitis | Pulmonary Fibrosis | Chest CT

Data type

boolean

Alias
UMLS CUI [1]
C0206061
UMLS CUI [2]
C0034069
UMLS CUI [3]
C0202823
active inflammatory bowel disease or other bowel disease causing chronic diarrhoea (defined as > 4 loose stools per day).
Description

Inflammatory Bowel Disease Causing Chronic diarrhea | Intestinal Disease Causing Chronic diarrhea | Loose stool Quantity per day

Data type

boolean

Alias
UMLS CUI [1,1]
C0021390
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0401151
UMLS CUI [2,1]
C0021831
UMLS CUI [2,2]
C0678227
UMLS CUI [2,3]
C0401151
UMLS CUI [3,1]
C2129214
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0439505
history of gilbert's syndrome or dihydropyrimidine deficiency.
Description

Gilbert Disease | Dihydropyrimidine Dehydrogenase Deficiency

Data type

boolean

Alias
UMLS CUI [1]
C0017551
UMLS CUI [2]
C1959620
known positive test for human immunodeficiency virus infection, hepatitis c virus, chronic active hepatitis b infection.
Description

HIV Seropositivity | Hepatitis C positive | Chronic active hepatitis B

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1112419
UMLS CUI [3]
C0744831
any investigational agent within 30 days before initiation of study treatment.
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
must not have had a major surgical procedure within 28 days prior to initiation of study treatment.
Description

major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
subject who is pregnant or breast-feeding.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
woman or man of childbearing potential not consenting to use adequate contraceptive precautions during the course of the study and for six months after the last study drug administration for women, and one month for men.
Description

Childbearing Potential Contraceptive methods Unwilling | Gender

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
UMLS CUI [2]
C0079399
other protocol specified criteria and specific details may apply.
Description

Clinical Trial Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Metastatic Colorectal Cancer NCT00508404

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
COLON ADENOCARCINOMA METASTATIC | Adenocarcinoma of rectum metastatic
Item
diagnosed with histologically- or cytologically-confirmed metastatic adenocarcinoma of the colon and/or rectum.
boolean
C0742581 (UMLS CUI [1])
C0149978 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
Measurable Disease
Item
measurable disease according to modified recist guidelines.
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0, 1 or 2.
boolean
C1520224 (UMLS CUI [1])
Primary tumor Paraffin Embedded Tissue Available | Neoplasm Metastasis Paraffin Embedded Tissue Available | Primary tumor Unstained Specimen Available | Neoplasm Metastasis Unstained Specimen Available
Item
paraffin-embedded tissue or unstained tumour slides from primary or metastatic tumour available for central lab analysis.
boolean
C0677930 (UMLS CUI [1,1])
C1519524 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2,1])
C1519524 (UMLS CUI [2,2])
C0470187 (UMLS CUI [2,3])
C0677930 (UMLS CUI [3,1])
C1883469 (UMLS CUI [3,2])
C0470187 (UMLS CUI [3,3])
C0027627 (UMLS CUI [4,1])
C1883469 (UMLS CUI [4,2])
C0470187 (UMLS CUI [4,3])
Hematologic function | Renal function | Liver function | Metabolic function normal
Item
adequate haematologic, renal, hepatic and metabolic function.
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0438212 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
CNS metastases
Item
central nervous system metastases.
boolean
C0686377 (UMLS CUI [1])
Systemic therapy Colorectal cancer metastatic | Exception Adjuvant Chemotherapy Fluoropyrimidine
Item
prior systemic therapy for the treatment of metastatic colorectal carcinoma with the exception of adjuvant fluoropyrimidine-based chemotherapy given at least six months prior to initiating study treatment.
boolean
C1515119 (UMLS CUI [1,1])
C0948380 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0085533 (UMLS CUI [2,2])
C0596581 (UMLS CUI [2,3])
EGFR Antibody Therapeutic procedure | cetuximab | Small Molecule EGFR Tyrosine Kinase Inhibitor Therapy | erlotinib
Item
prior anti-egfr antibody therapy (e.g.: cetuximab) or treatment with small molecule egfr tyrosine kinase inhibitors (e.g.: erlotinib).
boolean
C4055105 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0995188 (UMLS CUI [2])
C1328819 (UMLS CUI [3,1])
C3899317 (UMLS CUI [3,2])
C1135135 (UMLS CUI [4])
Therapeutic radiology procedure | Toxicity Signs Abate Lacking
Item
prior radiotherapy within 14 days prior to screening, and for which all signs of early radiological toxicity have not abated.
boolean
C1522449 (UMLS CUI [1])
C0600688 (UMLS CUI [2,1])
C0311392 (UMLS CUI [2,2])
C3853704 (UMLS CUI [2,3])
C0332268 (UMLS CUI [2,4])
Cardiovascular Diseases | Angina, Unstable | Myocardial Infarction | Ventricular arrhythmia
Item
significant cardiovascular disease including unstable angina or myocardial infarction within six months before initiating study treatment or a history of ventricular arrhythmia.
boolean
C0007222 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0085612 (UMLS CUI [4])
Interstitial Pneumonitis | Pulmonary Fibrosis | Chest CT
Item
history of interstitial pneumonitis or pulmonary fibrosis or evidence of interstitial pneumonitis or pulmonary fibrosis on baseline chest ct scan.
boolean
C0206061 (UMLS CUI [1])
C0034069 (UMLS CUI [2])
C0202823 (UMLS CUI [3])
Inflammatory Bowel Disease Causing Chronic diarrhea | Intestinal Disease Causing Chronic diarrhea | Loose stool Quantity per day
Item
active inflammatory bowel disease or other bowel disease causing chronic diarrhoea (defined as > 4 loose stools per day).
boolean
C0021390 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0401151 (UMLS CUI [1,3])
C0021831 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0401151 (UMLS CUI [2,3])
C2129214 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0439505 (UMLS CUI [3,3])
Gilbert Disease | Dihydropyrimidine Dehydrogenase Deficiency
Item
history of gilbert's syndrome or dihydropyrimidine deficiency.
boolean
C0017551 (UMLS CUI [1])
C1959620 (UMLS CUI [2])
HIV Seropositivity | Hepatitis C positive | Chronic active hepatitis B
Item
known positive test for human immunodeficiency virus infection, hepatitis c virus, chronic active hepatitis b infection.
boolean
C0019699 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
C0744831 (UMLS CUI [3])
Investigational New Drugs
Item
any investigational agent within 30 days before initiation of study treatment.
boolean
C0013230 (UMLS CUI [1])
major surgery
Item
must not have had a major surgical procedure within 28 days prior to initiation of study treatment.
boolean
C0679637 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
subject who is pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Unwilling | Gender
Item
woman or man of childbearing potential not consenting to use adequate contraceptive precautions during the course of the study and for six months after the last study drug administration for women, and one month for men.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol specified criteria and specific details may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial